• Blog
  • Blog - Claria
  • Media
  • Careers
  • Events
  • Sitemap
  • Contact
  • Email Us
    contact@medgenome.com
  • About Us
    • Company
    • Management
    • Directors
    • Advisors
    • Our Investors
    • MedGenome Institutional Ethics Committee (MG-IEC)
  • Genetic Testing
    • By Disease
      • Cardiology
      • Connective Tissue Disorders
      • Dermatology
      • Endocrinology
      • ENT
      • Haematology
      • Immunology
      • Metabolic Disorders
      • Miscellaneous
      • Nephrology
      • Neurology
      • Oncology
      • Ophthalmology
    • Non-Invasive Prenatal Test
    • About Us
      • Company
      • Management
      • Directors
      • Advisors
      • Our Investors
      • MedGenome Institutional Ethics Committee (MG-IEC)
    • Genetic Testing in South Asia
      • - By Disease
        • Cardiology
        • Connective Tissue Disorders
        • Dermatology
        • Endocrinology
        • ENT
        • Haematology
        • Immunology
        • Metabolic Disorders
        • Miscellaneous
        • Nephrology
        • Neurology
        • Oncology
      • Non-Invasive Prenatal Test
    • Publications
  • Next Generation Sequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • miRNA Sequencing
  • ChIP Sequencing
  • MethylSeq
  • TCR Sequencing
  • NGS Bioinformatics
  • Cloning & Stable Cell Line Development
  • CAP/CLIA Certified Services
  • Single-gene Sequencing
  • BRAF V600E
  • CAP/CLIA/GCLP Clinical Research
  • Contact us for more information
  • Research and Development Services
  • Exome Sequencing
  • RNA Sequencing
  • Single-gene Sequencing
CLIA certified, CAP accredited, ISO15189 compliant Next Generation Sequencing Lab in California
Leading provider of genomic research services

MedGenome is a founding member of GenomeAsia 100K, an initiative to sequence 100,000 genomes in South, North and East Asian Population

VIEW MORE INFORMATION

MedGenome has CAP/CLIA certified NGS lab in Foster City, California and two other state of art sequencing labs in Bangalore and Cochin

Integrated Genomics Platform

Integrated Genomics Platform (IGP) empowers genetic research studies into complex human diseases otherwise intractable by conventional genetic analysis. This service enables pharma to develop better drugs by applying genomics to stratified disease cohorts
VIEW MORE INFORMATION
Understanding the genetic basis of complex diseases and rare disorders
  • Develop better diagnostics
  • Uncover causal genes in orphan Mendelian disorders
Enables novel drug development
  • Genetic breakthroughs have produced blockbuster drugs and diagnostics
Elucidate the genetic keys to human health
  • Centenarian studies
  • Discovery of protective alleles in a population

IGP enables pharma to develop better drugs by applying genomics to stratified disease cohorts

Genomic Solutions – OncoPept

OncoPept is an end-to-end genomics platform to accelerate your immuno-oncology research

MedGenome is the only Next Generation Sequencing (NGS) service provider offering immuno-oncology researchers an enduring, science-driven partnership to deliver quicker, more affordable, customized solutions to achieve superior therapeutic impact of checkpoint control inhibitors and cancer vaccines through its cancer immunotherapy platform, OncoPeptTM

VIEW MORE INFORMATION
Genomic Solutions – OncoMD

OncoMD is an extensively annotated knowledge base of genomic alterations in cancer that provides deep insights into the disease at a genetic and molecular level

OncoMD combines curated data with software bioinformatics and powerful analytics to derive useful genomics solutions in cancer research and diagnostics

  • 1,900,000+

    Cancer mutations

  • 7,000+

    Peer reviewed publications

  • 17,000+

    Exome studies

  • 650,000+

    Samples
VIEW MORE INFORMATION

NGS Informatics

MedGenome’s NGS Informatics team consisting of biologists, bio-informaticians and statisticians are available on a fee per project or contract basis to analyze your data to drive genomics research. They are your resource for data analysis utilizing your company’s pipeline, commercial pipelines or MedGenome-derived analysis plans

Data Analysis

Variant calling | Gene expression | T-cell neo-epitope identification | Tumor microenvironment analysis | Epigenetic regulation | Genotype – phenotype correlation | Gene signature analysis

Data Sources

Mouse studies | Primates | Microbiome | Human preclinical and clinical trials

Areas of Expertise

Data Type

Whole Genome analysis | Exome | RNAseq | Chipseq | Methylseq | miRNA | Small RNA analysis | Microarray | Clinical

Disease Areas

Oncology | Neurology | Cardiovascular | Diabetes | Ophthalmology | ENT | Autoimmune | Pre-natal | Rare diseases | Population Genomics/Longevity
VIEW MORE INFORMATION

Non-Invasive Prenatal Screening Test

MedGenome is the first to offer NIPT testing for chromosomal disorders in India
VIEW MORE INFORMATION

Integrated Genomics Platform

Integrated Genomics Platform (IGP) empowers genetic research studies into complex human diseases otherwise intractable by conventional genetic analysis. This service enables pharma to develop better drugs by applying genomics to stratified disease cohorts
VIEW MORE INFORMATION

IGP enables pharma to develop better drugs by applying genomics to stratified disease cohorts

Elucidate the genetic keys to human health
  • Centenarian studies
  • Discovery of protective alleles in a population
Understanding the genetic basis of complex diseases and rare disorders
  • Develop better diagnostics
  • Uncover causal genes in orphan Mendelian disorders
Enables novel drug development
  • Genetic breakthroughs have produced blockbuster drugs and diagnostics

Genomic Solutions – OncoPept

OncoPept is an end-to-end genomics platform to accelerate your immuno-oncology research

MedGenome is the only Next Generation Sequencing (NGS) service provider offering immuno-oncology researchers an enduring, science-driven partnership to deliver quicker, more affordable, customized solutions to achieve superior therapeutic impact of checkpoint control inhibitors and cancer vaccines through its cancer immunotherapy platform, OncoPeptTM


VIEW MORE INFORMATION

Genomic Solutions – OncoMD

OncoMD is an extensively annotated knowledge base of genomic alterations in cancer that provides deep insights into the disease at a genetic and molecular level

OncoMD combines curated data with software bioinformatics and powerful analytics to derive useful genomics solutions in cancer research and diagnostics

  • 1,900,000+

    Cancer mutations

  • 7,000+

    Peer reviewed publications

  • 17,000+

    Exome studies

  • 650,000+

    Samples

NGS Informatics

MedGenome’s NGS Informatics team consisting of biologists, bio-informaticians and statisticians are available on a fee per project or contract basis to analyze your data to drive genomics research. They are your resource for data analysis utilizing your company’s pipeline, commercial pipelines or MedGenome-derived analysis plans

Areas of Expertise

Data Analysis

Variant calling | Gene expression | T-cell neo-epitope identification | Tumor microenvironment analysis | Epigenetic regulation | Genotype – phenotype correlation | Gene signature analysis

Data Sources

Mouse studies | Primates | Microbiome | Human preclinical and clinical trials

Data Type

Whole Genome analysis | Exome | RNAseq | Chipseq | Methylseq | miRNA | Small RNA analysis | Microarray | Clinical

Disease Areas

Oncology | Neurology | Cardiovascular | Diabetes | Ophthalmology | ENT | Autoimmune | Pre-natal | Rare diseases | Population Genomics/Longevity
VIEW MORE INFORMATION

NIPT MedGenome is the first to offerNIPT testing for chromosomaldisorders in India
VIEW MORE INFORMATION

About MedGenome

MedGenome Inc. is a genomics-based research company headquartered in California with a mission to improve global health by decoding genetic information contained in an individual's genome

About Us

Genetic Testing

Publications

  • Company
  • Management
  • Directors
  • Advisors
  • Our Investors
  • MedGenome Institutional Ethics Committee (MG-IEC)
  • By Disease
    • Cardiology
    • Connective Tissue Disorders
    • Dermatology
    • Endocrinology
    • ENT
    • Haematology
    • Immunology
    • Metabolic Disorders
    • Miscellaneous
    • Nephrology
    • Neurology
    • Oncology
  • Non-Invasive Prenatal Test

2017 © MedGenome. All Rights Reserved.

  • Blog
  • Blog - Claria
  • Media
  • Careers
  • Events
  • Sitemap
  • Contact
Sitemap

  • Company
  • Management
  • Directors
  • Advisors
  • Our Investors
  • MedGenome Institutional Ethics Committee (MG-IEC)

  • By Disease
    • Cardiology
    • Connective Tissue Disorders
    • Dermatology
    • Endocrinology
    • ENT
    • Haematology
    • Immunology
    • Metabolic Disorders
    • Miscellaneous
    • Nephrology
    • Neurology
    • Oncology
  • Non-Invasive Prenatal Test

  • Blog
  • Media
  • Careers
  • Events
  • Sitemap
  • Contact

2017 © Medgenome. All Rights Reserved.